Why autism therapies have an evidence problem
Early interventions for autism lack solid data. The source of this problem is murky but may stem from ongoing debates about evidence quality and entrenched conflicts of interest within the field.
Early interventions for autism lack solid data. The source of this problem is murky but may stem from ongoing debates about evidence quality and entrenched conflicts of interest within the field.
Tony Charman and Catherine Lord answer questions from Spectrum’s webinar on the Lancet Commission’s recommendations for autism research.
A failed replication and other problems led autism researcher Beth Stevens and her co-investigator to retract the nearly 10-year-old report.
Autism studies are appearing in the reference lists of entirely unrelated papers, suggesting what a few scholars worry is a plot to manipulate citations.
Researchers requested the retraction of their study linking low vitamin A levels to sleep troubles in autistic children after discovering “fundamental errors” in their data.
Use of the term ‘profound autism’ is among the recommendations made by a panel of autism researchers, clinicians, autistic adults and parents of autistic people.
When scientists successfully partner with autistic people, the autistic community gains a voice in autism research, and the data are more reliable, experts say. Here’s how to build a successful collaboration.
In this edition of Null and Noteworthy, tests of intranasal oxytocin and an Angelman syndrome treatment fail to see results.
An autism brain imaging study published seven years ago received an expression of concern last month after its authors failed to uphold a promise to make their raw data freely available.
Studies of autism subtypes rarely validate their results, and this has led to a proliferation of autism subtypes of questionable utility. But reliable subtyping can help improve the prognosis for and care of autistic people.